3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
3
Triple Negative Breast Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Rectal Cancer Patients
1
Pancreatic Neoplasms
1
Locally Advanced Rectal Cancer
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Cisplatin
4
ribociclib
3
pembrolizumab
3
durvalumab
3
abemaciclib
3
Pemetrexed
3
Fulvestrant
3
Carboplatin
3
palbociclib
2
Nivolumab
2
Letrozole
2
Bevacizumab
2
Anastrozole
2
AZD9833
2
130-nm albumin-bound paclitaxel
2
selpercatinib
1
selinexor
1
repotrectinib
1
relatlimab
1
relacorilant
1
olaparib
1
gallium 68 PSMA-11
1
exemestane
1
enfortumab vedotin
1
elacestrant
1
darolutamide
1
cemiplimab
1
atezolizumab
1
Tamoxifen
1
Sunitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms by Site
×
camrelizumab
×
90 days
×
Clear all
No trials found.